Literature DB >> 2100283

Osteoporosis and diabetes: lessons from the diabetic BB rat.

J Verhaeghe1, W J Visser, T A Einhorn, R Bouillon.   

Abstract

The spontaneously diabetic BB rat was used to study the effect of diabetes on bone. Short-term diabetes (3-4 weeks) resulted in a state of low bone turnover, characterized by a severe decrease in osteoblast/osteoid surface and bone mineral apposition rate on histology, and in serum osteocalcin concentrations. If diabetes was long-term (12 weeks), the parameters of low bone formation were associated with histological evidence of osteoporosis and a decreased bone strength; the relative bone calcium concentration remained normal in diabetes. We conclude that long-standing diabetes results in a low-turnover osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2100283     DOI: 10.1159/000181834

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  12 in total

1.  Trabecular bone histomorphometry in humans with Type 1 Diabetes Mellitus.

Authors:  Laura A G Armas; Mohammed P Akhter; Andjela Drincic; Robert R Recker
Journal:  Bone       Date:  2011-10-07       Impact factor: 4.398

2.  Impaired osteogenic differentiation and enhanced cellular receptor of advanced glycation end products sensitivity in patients with type 2 diabetes.

Authors:  Mattabhorn Phimphilai; Peraphan Pothacharoen; Prachya Kongtawelert; Nipon Chattipakorn
Journal:  J Bone Miner Metab       Date:  2016-11-21       Impact factor: 2.626

Review 3.  Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.

Authors:  Kathryn M Thrailkill; Charles K Lumpkin; R Clay Bunn; Stephen F Kemp; John L Fowlkes
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11       Impact factor: 4.310

4.  Bone metabolism in male patients with type 2 diabetes.

Authors:  Lahsen Achemlal; Saida Tellal; Fouad Rkiouak; Abderrazak Nouijai; Ahmed Bezza; El Mostapha Derouiche; Driss Ghafir; Abdellah El Maghraoui
Journal:  Clin Rheumatol       Date:  2005-03-04       Impact factor: 2.980

5.  Type 2 diabetic mice demonstrate slender long bones with increased fragility secondary to increased osteoclastogenesis.

Authors:  Yuki Kawashima; J Christopher Fritton; Shoshana Yakar; Sol Epstein; Mitchell B Schaffler; Karl J Jepsen; Derek LeRoith
Journal:  Bone       Date:  2008-12-24       Impact factor: 4.398

6.  The effect of locally delivered recombinant human bone morphogenetic protein-2 with hydroxyapatite/tri-calcium phosphate on the biomechanical properties of bone in diabetes-related osteoporosis.

Authors:  Frank A Liporace; Eric A Breitbart; Richard S Yoon; Erin Doyle; David N Paglia; Sheldon Lin
Journal:  J Orthop Traumatol       Date:  2014-11-25

Review 7.  The alliance of mesenchymal stem cells, bone, and diabetes.

Authors:  Nicola Napoli; Rocky Strollo; Angela Paladini; Silvia I Briganti; Paolo Pozzilli; Sol Epstein
Journal:  Int J Endocrinol       Date:  2014-07-16       Impact factor: 3.257

Review 8.  Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes.

Authors:  Deborah E Sellmeyer; Roberto Civitelli; Lorenz C Hofbauer; Sundeep Khosla; Beata Lecka-Czernik; Ann V Schwartz
Journal:  Diabetes       Date:  2016-07       Impact factor: 9.461

9.  Streptozotocin, type I diabetes severity and bone.

Authors:  Katherine Motyl; Laura R McCabe
Journal:  Biol Proced Online       Date:  2009-03-06       Impact factor: 3.244

10.  Myeloid thrombomodulin lectin-like domain inhibits osteoclastogenesis and inflammatory bone loss.

Authors:  Tsung-Lin Cheng; Chao-Han Lai; Shyh-Jou Shieh; Yin-Bo Jou; Jwu-Lai Yeh; Ai-Lun Yang; Yan-Hsiung Wang; Chau-Zen Wang; Chung-Hwan Chen; Guey-Yueh Shi; Mei-Ling Ho; Hua-Lin Wu
Journal:  Sci Rep       Date:  2016-06-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.